The proportion of individuals with a negative test primarily affects which predictive value?

Prepare for the NBME Form 9 Test with our engaging quiz. Utilize multiple choice questions and explanations. Excel in your exam with thorough study tools and resources!

Multiple Choice

The proportion of individuals with a negative test primarily affects which predictive value?

Explanation:
Focusing on predictive values, the main idea is that a negative predictive value answers “Among those who test negative, how many truly do not have the disease?” This makes it directly tied to how many people end up with a negative result. NPV is calculated as true negatives divided by all negatives (true negatives plus false negatives). Therefore, when a larger proportion of individuals receive a negative test, there are more cases in the denominator, and the NPV reflects that negative-result group. In practice, NPV tends to be higher when disease prevalence is low, because a larger share of those who test negative are truly disease-free. The other measures are more about the test’s inherent ability to identify disease among those tested (sensitivity) or among those without disease (specificity), and they don’t hinge on how many people end up testing negative in the tested population. PPV, for instance, concerns positives and the probability that a positive result is truly diseased.

Focusing on predictive values, the main idea is that a negative predictive value answers “Among those who test negative, how many truly do not have the disease?” This makes it directly tied to how many people end up with a negative result. NPV is calculated as true negatives divided by all negatives (true negatives plus false negatives). Therefore, when a larger proportion of individuals receive a negative test, there are more cases in the denominator, and the NPV reflects that negative-result group. In practice, NPV tends to be higher when disease prevalence is low, because a larger share of those who test negative are truly disease-free. The other measures are more about the test’s inherent ability to identify disease among those tested (sensitivity) or among those without disease (specificity), and they don’t hinge on how many people end up testing negative in the tested population. PPV, for instance, concerns positives and the probability that a positive result is truly diseased.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy